The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3-chlorophenoxy)-1-((1-methylpiperidin-4-yl)methyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ID: ALA4090973
PubChem CID: 130431659
Max Phase: Preclinical
Molecular Formula: C18H21ClN6O
Molecular Weight: 372.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(Cn2nc(Oc3cccc(Cl)c3)c3c(N)ncnc32)CC1
Standard InChI: InChI=1S/C18H21ClN6O/c1-24-7-5-12(6-8-24)10-25-17-15(16(20)21-11-22-17)18(23-25)26-14-4-2-3-13(19)9-14/h2-4,9,11-12H,5-8,10H2,1H3,(H2,20,21,22)
Standard InChI Key: OWAHNIJXSIARTN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
6.2032 -6.3889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4130 -4.9980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4119 -5.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1199 -6.2265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1181 -4.5892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8267 -4.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8315 -5.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6116 -6.0615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0889 -5.3964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6038 -4.7370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8686 -6.8372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1157 -3.7720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8518 -3.9583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6501 -3.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1971 -4.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9947 -4.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2434 -3.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6882 -2.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8926 -3.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9334 -2.0496 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.6689 -7.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9212 -7.7777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7176 -7.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2642 -7.3362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0087 -6.5590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0639 -7.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
8 11 1 0
5 12 1 0
10 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
18 20 1 0
11 21 1 0
21 22 1 0
21 1 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 1 1 0
24 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.86Molecular Weight (Monoisotopic): 372.1465AlogP: 3.20#Rotatable Bonds: 4Polar Surface Area: 82.09Molecular Species: BASEHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.19CX LogP: 2.82CX LogD: 1.03Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.32
References 1. Rutaganira FU, Barks J, Dhason MS, Wang Q, Lopez MS, Long S, Radke JB, Jones NG, Maddirala AR, Janetka JW, El Bakkouri M, Hui R, Shokat KM, Sibley LD.. (2017) Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii., 60 (24): [PMID:28933846 ] [10.1021/acs.jmedchem.7b01192 ]